Doctor Tomoyuki Nagai
Kyoto Prefectural University of Medicine, Kyoto (Japan)
Efficacy and safety of long-term edoxaban treatment for low body weight cancer patients with isolated distal deep vein thrombosis: a post-hoc subgroup analysis of the ONCO DVT study
Event: ESC Congress 2024
Topic: Venous Thromboembolism
Session: Pearls of acute pulmonary embolism
Management of doxorubicin-induced cardiomyopathy as the adverse event of chemotherapy in acute critical decompensated heart failure: a case report.
Event: ESC Congress 2022
Topic: Cardio-Oncology
Session: Cardio-oncology – Cancer treatment and cardiovascular toxicity
